Tech Company Financing Transactions
Tremeau Pharmaceuticals Funding Round
Private investors participated in a $5.2 million capital raise for Tremeau Pharmaceuticals. The round was announced on 2/16/2018.
Transaction Overview
Company Name
Announced On
2/16/2018
Transaction Type
Venture Equity
Amount
$5,200,000
Round
Undisclosed
Investors
Proceeds Purpose
The funding will be used to advance Tremeau's pipeline of non-opioid pain treatment candidates.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Bdwy. 14th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
Tremeau Pharmaceuticals is a Massachusetts based privately funded clinical stage company focused on commercializing non-opioid pain therapies targeting serious rare diseases impacted by the cyclooxygenase (COX) or prostanoid pathways. We focus exclusively on orphan or unique disease states with high unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bradford Sippy
VP - R & D
Mark Corrigan
VP - Regulatory Affairs
Stewart Mueller
Browse more venture capital transactions:
Prev: 2/16/2018: Dwolla venture capital transaction
Next: 2/16/2018: Yerdle venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs